Merck Wins Second Vioxx Trial, But Total Liability Still Hard to Pin Down

Drug Industry Daily
A A

Merck emerged victorious Nov. 3 in the second lawsuit over its withdrawn painkiller Vioxx, but analysts cautioned that -- with more than 6,000 cases still pending and many more likely to be filed -- the drugmaker is far from out of the woods.

To View This Article:

Login

Subscribe To Drug Industry Daily